300832 Shenzhen New Industries Biomedical Engineering Co.,Ltd.
Closed 12-25 15:00:00
71.11
-0.22
-0.31%
High
72.03
Low
70.50
Vol
2.54M
Open
71.65
D1 Closing
71.33
Amplitude
2.14%
Mkt Cap
55.89B
Tradable Cap
48.35B
Total Shares
786.00M
T/O
180.00M
T/O Rate
0.37%
Tradable Shares
680.00M
P/B
6.9
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
Shenzhen New Industries Q3 Net Profit up 10.0% Y/Y
THOMSON REUTERS · 10-28
Shenzhen New Industries Q3 Net Profit up 10.0% Y/Y
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 95.79 Yuan From 95.86 Yuan, Keeps at Buy
MT Newswires Live · 10-16
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 95.79 Yuan From 95.86 Yuan, Keeps at Buy
Shenzhen New Industries Biomedical Engineering's H1 Profit Jumps 20%, Operating Income Up 19%
MT Newswires Live · 08-23
Shenzhen New Industries Biomedical Engineering's H1 Profit Jumps 20%, Operating Income Up 19%
Shenzhen New Industries Biomedical Says H1 Net Profit up 20.4% Y/Y
THOMSON REUTERS · 08-22
Shenzhen New Industries Biomedical Says H1 Net Profit up 20.4% Y/Y
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Antiphospholipid Assay Kit
MT Newswires Live · 08-15
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Antiphospholipid Assay Kit
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Antiphospholipid Assay Kit
MT Newswires Live · 08-15
Shenzhen New Industries Biomedical Engineering Gets Nod to Register Antiphospholipid Assay Kit
Load more
Introduction
Company Name.
深圳市新产业生物医学工程股份有限公司
Industry:
医药制造业
Listing Date:
2020-05-12
Main Business:
深圳市新产业生物医学工程股份有限公司主营业务是体外诊断领域产品的研发、生产销售及客户服务。公司产品主要用于提供疾病的预防、诊断、治疗监测、预后观察、健康状态评价以及遗传性疾病预测的诊断信息。新产业生物公司是中国第一家采用最先进的“纳米免疫磁性微珠”作为系统的关键分离材料的公司、中国第一家采用目前该领域最先进的“人工合成的小分子有机化合物”代替传统的酶作为发光标记物的公司、中国第一家应用直接化学发光免疫分析技术并实现批量生产全自动化学发光免疫分析仪器及配套试剂的公司。
Issue price:
31.39
{"stockData":{"symbol":"300832","market":"SZ","secType":"STK","nameCN":"Shenzhen New Industries Biomedical Engineering Co.,Ltd.","latestPrice":71.11,"timestamp":1735110231000,"preClose":71.33,"halted":0,"volume":2539860,"delay":0,"changeRate":-0.0031,"floatShares":680000000,"shares":786000000,"eps":2.3553,"marketStatus":"Closed","change":-0.22,"latestTime":"12-25 15:00:00","open":71.65,"high":72.03,"low":70.5,"amount":180000000,"amplitude":0.0214,"askPrice":71.14,"askSize":2,"bidPrice":71.11,"bidSize":10,"shortable":0,"etf":0,"ttmEps":2.3553,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1735176600000},"marketStatusCode":5,"adr":0,"adjPreClose":71.33,"symbolType":"stock","openAndCloseTimeList":[[1735090200000,1735097400000],[1735102800000,1735110000000]],"highLimit":78.46,"lowLimit":64.2,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":785718785,"isCdr":false,"pbRate":6.9,"roa":"--","peRate":30.191483,"roe":"17.54%","epsLYR":2.1054,"committee":0.27572,"marketValue":55872000000,"turnoverRate":0.0037,"status":1,"floatMarketCap":48370000000},"requestUrl":"/m/hq/s/300832","defaultTab":"news","newsList":[{"id":"2478176520","title":"Shenzhen New Industries Q3 Net Profit up 10.0% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2478176520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2478176520?lang=en_us&edition=fundamental","pubTime":"2024-10-28 16:56","pubTimestamp":1730105796,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241028:nL4N3M40L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["300832","BK0239"],"gpt_icon":0},{"id":"2475097984","title":"Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 95.79 Yuan From 95.86 Yuan, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2475097984","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475097984?lang=en_us&edition=fundamental","pubTime":"2024-10-16 15:09","pubTimestamp":1729062582,"startTime":"0","endTime":"0","summary":"Shenzhen New Industries Biomedical Engineering (SHE:300832) has an average rating of buy and price targets ranging from 73.73 yuan to 104.80 yuan, according to analysts polled by Capital IQ.(MT Newswi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMR","300832"],"gpt_icon":0},{"id":"2461611589","title":"Shenzhen New Industries Biomedical Engineering's H1 Profit Jumps 20%, Operating Income Up 19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461611589","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461611589?lang=en_us&edition=fundamental","pubTime":"2024-08-23 11:14","pubTimestamp":1724382894,"startTime":"0","endTime":"0","summary":"Shenzhen New Industries Biomedical Engineering recorded a net profit attributable to shareholders of 903.1 million yuan in the first half of the year, jumping 20.4% from the year-ago profit of almost 750 million yuan, according to a Friday disclosure on the Shenzhen Stock Exchange.Earnings per share rose 20.5% year on year to 1.15 yuan from 0.95 yuan.The Chinese biomedical technology company generated an operating income worth 2.21 billion yuan, up 18.5% from 1.87 billion yuan in the previous year.Shares of the company rose less than 2% in recent trade.Price : 63.85, Change: +0.92, Percent Change: +1.46%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300832"],"gpt_icon":0},{"id":"2461189364","title":"Shenzhen New Industries Biomedical Says H1 Net Profit up 20.4% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2461189364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461189364?lang=en_us&edition=fundamental","pubTime":"2024-08-22 16:30","pubTimestamp":1724315407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240822:nL4N3K90NY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","300832"],"gpt_icon":0},{"id":"2459710491","title":"Shenzhen New Industries Biomedical Engineering Gets Nod to Register Antiphospholipid Assay Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=2459710491","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459710491?lang=en_us&edition=fundamental","pubTime":"2024-08-15 13:49","pubTimestamp":1723700954,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK0239","A7RU.SI","SG9999003826.SGD","BK6501","SG9999001069.SGD","SG9999003461.SGD","SHE","300832","SG9999004360.SGD","BK6031","BK6102","SG9999002950.SGD"],"gpt_icon":0},{"id":"2459051491","title":"Shenzhen New Industries Biomedical Engineering Gets Nod to Register Antiphospholipid Assay Kit","url":"https://stock-news.laohu8.com/highlight/detail?id=2459051491","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459051491?lang=en_us&edition=fundamental","pubTime":"2024-08-15 13:49","pubTimestamp":1723700954,"startTime":"0","endTime":"0","summary":"The drug administration of China's Guangdong Province granted a medical device registration certificate to Shenzhen New Industries Biomedical Engineering's antiphospholipid antibody IgA assay kit , according to a Wednesday disclosure on the Shenzhen Stock Exchange.The certificate is valid until Aug. 5, 2029, the Chinese biomedical technology company said.Shares of the company slipped less than 2% in recent trade.Price : 62.48, Change: -0.86, Percent Change: -1.36%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["A7RU.SI","SG9999004360.SGD","SG9999003826.SGD","300832","SG9999002950.SGD","BK6102","SG9999003461.SGD","BK0239","BK6031","SG9999001069.SGD","BK6501"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-05-12","address":"广东省深圳市坪山区坑梓街道金沙社区锦绣东路23号新产业生物大厦二十一层","stockEarnings":[{"period":"1week","weight":0.0494},{"period":"1month","weight":0.16},{"period":"3month","weight":0.0159},{"period":"6month","weight":0.0544},{"period":"1year","weight":-0.0482},{"period":"ytd","weight":-0.0787}],"companyName":"深圳市新产业生物医学工程股份有限公司","boardCode":"AI0027","perCapita":"58492股","boardName":"医药制造业","registeredCapital":"78571万元","compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":0.0397},{"period":"3month","weight":0.1308},{"period":"6month","weight":0.1435},{"period":"1year","weight":0.1706},{"period":"ytd","weight":0.1406}],"survey":" 深圳市新产业生物医学工程股份有限公司主营业务是体外诊断领域产品的研发、生产销售及客户服务。公司产品主要用于提供疾病的预防、诊断、治疗监测、预后观察、健康状态评价以及遗传性疾病预测的诊断信息。新产业生物公司是中国第一家采用最先进的“纳米免疫磁性微珠”作为系统的关键分离材料的公司、中国第一家采用目前该领域最先进的“人工合成的小分子有机化合物”代替传统的酶作为发光标记物的公司、中国第一家应用直接化学发光免疫分析技术并实现批量生产全自动化学发光免疫分析仪器及配套试剂的公司。","serverTime":1735148435975,"listedPrice":31.39,"stockholders":"11629人(较上一季度减少17.66%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shenzhen New Industries Biomedical Engineering Co.,Ltd.(300832),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shenzhen New Industries Biomedical Engineering Co.,Ltd.(300832) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shenzhen New Industries Biomedical Engineering Co.,Ltd.,300832,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股票,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股票老虎,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股票老虎国际,Shenzhen New Industries Biomedical Engineering Co.,Ltd.行情,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股票行情,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股价,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股市,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股票价格,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股票交易,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股票购买,Shenzhen New Industries Biomedical Engineering Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shenzhen New Industries Biomedical Engineering Co.,Ltd.(300832),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shenzhen New Industries Biomedical Engineering Co.,Ltd.(300832) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}